Analysis of the beta-lactamase plasmid of borderline methicillin-susceptible Staphylococcus aureus: focus on bla complex genes and cadmium resistance determinants cadD and cadX.

Borderline methicillin-susceptible Staphylococcus aureus strains are a rather homogeneous group, characterized by MICs of penicillinase-resistant penicillins (PRPs) at or just below the susceptibility breakpoint. Other features unique to this group include the presence of a pBW15-like beta-lactamase plasmid, the association with phage complex 94/96, and the production of a PRP-hydrolyzing beta-lactamase activity in addition to the classical penicillinase activity. The four HindIII fragments of pBORa53, a pBW15-like plasmid from the well-studied borderline S. aureus strain a53, were cloned in Escherichia coli, sequenced and analyzed. The plasmid (17,334 bp in size) contains 14 open reading frames (ORFs) and a complete copy of transposon Tn552, which harbors the three genes of the bla complex (blaZ, blaR1, and blaI) necessary for penicillinase production. Among the other 11 ORFs identified, two were homologous to cadmium resistance determinants of Staphylococcus lugdunensis and to the cadD and cadX genes recently detected in S. aureus. Consistent with this, strain a53 was found to be cadmium resistant. From a collection of 30 S. aureus isolates with borderline PRP MIC levels, 27 matched strain a53 in the positive amplification reactions with all of the four primer pairs targeting the cadD-cadX region, the presence of the 17.3-kb plasmid, and the level of cadmium resistance. The well-established S. aureus laboratory strain ATCC 29213 was also found to express cadD-cadX-mediated cadmium resistance. pBORa53 could be re-isolated from transformants obtained by transferring it into a PRP-susceptible recipient. However, while the transformants demonstrated levels of cadmium and penicillin resistance similar to those of strain a53, they remained fully susceptible to PRPs.

[1]  P. Varaldo The 'borderline methicillin-susceptible' Staphylococcus aureus. , 1993, The Journal of antimicrobial chemotherapy.

[2]  J A Washington,et al.  Evaluation of Vitek GPS-SA card for testing of oxacillin against borderline-susceptible staphylococci that lack mec , 1996, Journal of clinical microbiology.

[3]  B. Barrell,et al.  Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[5]  M. P. Montanari,et al.  Cloning and expression of the penicillinase from a borderline methicillin-susceptible Staphylococcus aureus strain in Escherichia coli. , 1994, FEMS microbiology letters.

[6]  M. P. Montanari,et al.  Evidence for a methicillin-hydrolysing beta-lactamase in Staphylococcus aureus strains with borderline susceptibility to this drug. , 1992, FEMS microbiology letters.

[7]  R. Novick Molecular Biology of the Staphylococci , 1990 .

[8]  Tetsuya Hayashi,et al.  Complete Nucleotide Sequence of aStaphylococcus aureus Exfoliative Toxin B Plasmid and Identification of a Novel ADP-Ribosyltransferase, EDIN-C , 2001, Infection and Immunity.

[9]  R. Skurray,et al.  Genetics: Accessory Elements and Genetic Exchange , 2006 .

[10]  G. Archer,et al.  Crystal Structures of the BlaI Repressor from Staphylococcus aureus and Its Complex with DNA: Insights into Transcriptional Regulation of the bla and mec Operons , 2005, Journal of bacteriology.

[11]  M. Kanehisa,et al.  Whole genome sequencing of meticillin-resistant Staphylococcus aureus , 2001, The Lancet.

[12]  E. Asheshov,et al.  Properties of strains of Staphylococcus aureus in the 94, 96 complex. , 1977, Journal of medical microbiology.

[13]  O. Massidda,et al.  Borderline susceptibility to methicillin in Staphylococcus aureus: a new mechanism of resistance? , 1996, Microbial drug resistance.

[14]  J. Gustafson,et al.  Genetic characterization of the fusidic acid and cadmium resistance determinants of Staphylococcus aureus plasmid pUB101. , 2002, The Journal of antimicrobial chemotherapy.

[15]  T. Greenland,et al.  Nucleic acid sequence and affiliation of pLUG10, a novel cadmium resistance plasmid from Staphylococcus lugdunensis. , 1996, Plasmid.

[16]  R. Novick,et al.  Nucleotide sequence and expression of the beta-lactamase gene from Staphylococcus aureus plasmid pI258 in Escherichia coli, Bacillus subtilis, and Staphylococcus aureus , 1987, Journal of bacteriology.

[17]  Y. Nagai,et al.  Genome and virulence determinants of high virulence community-acquired MRSA , 2002, The Lancet.

[18]  M. O'Reilly,et al.  The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage , 1983, Nature.

[19]  M. P. Montanari,et al.  Further characterization of borderline methicillin-resistant Staphylococcus aureus and analysis of penicillin-binding proteins , 1990, Antimicrobial Agents and Chemotherapy.

[20]  G. Stewart,et al.  Cloning and Expression of cadD, a New Cadmium Resistance Gene of Staphylococcus aureus , 1999, Journal of bacteriology.

[21]  A. Tomasz,et al.  New mechanism for methicillin resistance in Staphylococcus aureus: clinical isolates that lack the PBP 2a gene and contain normal penicillin-binding proteins with modified penicillin-binding capacity , 1989, Antimicrobial Agents and Chemotherapy.

[22]  L. Mcdougal,et al.  The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins , 1986, Journal of clinical microbiology.

[23]  Vincent A. Fischetti,et al.  Gram-positive pathogens , 2006 .

[24]  K. Singh,et al.  Comparison of the beta-lactamase gene cluster in clonally distinct strains of Enterococcus faecalis , 1996, Antimicrobial agents and chemotherapy.

[25]  M. P. Montanari,et al.  Borderline methicillin-susceptible Staphylococcus aureus strains have more in common than reduced susceptibility to penicillinase-resistant penicillins , 1996, Antimicrobial agents and chemotherapy.

[26]  T. Kocagoz,et al.  Point mutations in Staphylococcus aureus PBP 2 gene affect penicillin-binding kinetics and are associated with resistance , 1995, Antimicrobial agents and chemotherapy.

[27]  J. Kornblum,et al.  Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus , 1988, Journal of bacteriology.

[28]  D. Kernodle,et al.  Characterization of a widespread strain of methicillin-susceptible Staphylococcus aureus associated with nosocomial infections. , 1990, The Journal of infectious diseases.

[29]  D. Kernodle,et al.  Borderline susceptibility to antistaphylococcal penicillins is not conferred exclusively by the hyperproduction of beta-lactamase , 1991, Antimicrobial Agents and Chemotherapy.

[30]  P. Kovács,et al.  Investigation of Oxacillin-Hydrolyzing Beta-Lactamase in Borderline Methicillin-Resistant Clinical Isolates of Staphylococcus aureus , 2001, Chemotherapy.

[31]  G. Archer,et al.  Low-level methicillin resistance in strains of Staphylococcus aureus , 1989, Antimicrobial Agents and Chemotherapy.

[32]  J. Maclowry,et al.  Phage pattern-specific oxacillin-resistant and borderline oxacillin-resistant Staphylococcus aureus in U.S. hospitals: epidemiological significance , 1992, Journal of clinical microbiology.

[33]  C. Stratton,et al.  Association of Borderline Oxacillin-Susceptible Strains of Staphylococcus aureus with Surgical Wound Infections , 1998, Journal of Clinical Microbiology.

[34]  K. Dyke,et al.  Tn552, a novel transposable element from Staphylococcus aureus , 1990, Molecular microbiology.

[35]  R. Novick,et al.  Nucleotide sequence of β-lactamase regulatory genes from staphylococcal plasmid p1258 , 1991 .

[36]  B. Berger-Bächi,et al.  Natural methicillin resistance in comparison with that selected by in-vitro drug exposure in Staphylococcus aureus. , 1989, The Journal of antimicrobial chemotherapy.

[37]  S. Schenk,et al.  Improved method for electroporation of Staphylococcus aureus , 1992 .

[38]  J. Gerberding,et al.  Comparison of conventional susceptibility tests with direct detection of penicillin-binding protein 2a in borderline oxacillin-resistant strains of Staphylococcus aureus , 1991, Antimicrobial Agents and Chemotherapy.